SBC Medical to Announce Q2 2025 Earnings on August 13, 2025

SBC Medical will announce its Q2 2025 financial results on August 13, 2025, before the U.S. market opens. The company will hold a conference call to discuss the financial results and take questions live. A replay of the conference call will be accessible until August 13, 2026. The earnings release, accompanying slides, and an archived webcast will be available on the Company's Investor Relations website.

SBC Medical Group Holdings Incorporated (Nasdaq: SBC), a global franchise and provider of services for aesthetic clinics, has scheduled its Q2 2025 financial results announcement for Wednesday, August 13, 2025, before the U.S. market opens. The company will hold a conference call on the same day at 8:30 am Eastern Time (or 9:30 pm Japan Time) to discuss the financial results and take questions live.

Investors and financial professionals are encouraged to register in advance for the conference call using the link provided below:
https://edge.media-server.com/mmc/p/ukc9sp9j

The earnings presentation materials will be available for viewing and download on the dedicated Conference Call viewing site starting 10 minutes before the conference call begins. A replay of the conference call will be accessible until August 13, 2026. The earnings release, accompanying slides, and an archived webcast of this conference call will be available on the Company’s Investor Relations website at https://ir.sbc-holdings.com/.

About SBC Medical
SBC Medical, headquartered in Irvine, California, and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms, staff management, booking reservations, assistance with employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement, provision of cosmetic products, licensing of medical technologies, trademark and brand use, IT software solutions, management of the franchisee clinic’s customer rewards program, and payment tools for the franchisee clinics.

Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company’s beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company’s control. These forward-looking statements reflect the Company’s current views with respect to, among other things, the Company’s product launch plans and strategies; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” “targets” or “hopes” or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify.

References:
[1] https://www.stocktitan.net/news/SBC/sbc-medical-to-announce-q2-2025-financial-results-and-hold-p1axjnp8nj03.html
[2] https://www.marketbeat.com/earnings/reports/2025-8-21-sbc-medical-group-holdings-incorporated-stock/
[3] https://www.quiverquant.com/news/Alector%2C+Inc.+to+Host+Conference+Call+for+Q2+2025+Results+and+Mid-Year+Business+Update